Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2 : I. Effects of some formulation parameters on microparticle characteristics

References

• Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology4th ed. Saunders Company, Philadelphia, PA, USA 2000
   Google Scholar
• Ahmed H. Electrophoretic analyses of protein. In: Principles and reactions of protein extraction. Purification and characterization. Boca Raton. CRC Press, Chapter 3, FL 2005; 71–131
   Google Scholar
• Araújo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces, 2009;72(1):48–56.
   Google Scholar
• Aubert-Pouessel A, Venier-Julienne M-C, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit J-P. In vitro study of GDNF release from biodegradable PLGA microspheres. J Controlled Release 2004; 95: 463–75
   PubMed Web of Science ®Google Scholar
• Barakat NS, Radwan MA. In vitro performance of carbamazepine loaded to various molecular weights of poly(d, l-lactide-co-glycolide). Drug Deliv 2006; 13: 9–18
   PubMed Web of Science ®Google Scholar
• Bernsen MR, Tang J-W, Everse LA, Koten JW, Den Otter W. Interleukin 2 (IL-2) therapy: Potential advantages of locoregional versus systemic administration. Cancer Treat Rev, 1999;25:73–82.
   Google Scholar
• Bittner B, Morlock M, Koll H, Winter G, Kissel T. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: Influence of the encapsulation technique and polymer purity on microspheres characteristics. Eur J Pharm Biopharm 1998; 45: 295–305
   PubMed Web of Science ®Google Scholar
• Boury F, Marchais H, Proust JE, Benoit JP. Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: Effects of polymer molecular weight and surface properties. J Controlled Release 1997; 45: 75–86
   Web of Science ®Google Scholar
• Cadée JA, De Groot CJ, Jiskoot W, Den Otter W, Hennink WE. Release of recombinant human interleukin-2 from dextran-based hydrogels. J Controlled Release 2002; 78: 1–13
   PubMed Web of Science ®Google Scholar
• Cegnar M, Kos J, Julijana Kristl J. Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: Development and fundamental studies on preservation of its activity. Eur J Pharm Sci 2004; 22: 357–64
   PubMed Web of Science ®Google Scholar
• Chen H, Yang W, Chen H, Liu L, Gao F, Yang X, Jiang Q, Zhang Q, Wang Y. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan. Colloids Surf B 2009; 73: 212–18
   PubMed Web of Science ®Google Scholar
• Curatolo L, Valsasına B, Caccia C, Raimondi GL, Orsini G, Bianchetti A. Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation. Cytokine 1997; 9(10)734–9
   PubMedGoogle Scholar
• Den Otter W, Jacobs JJL, Battermann JJ, Hordijk GJ, Krastev Z, Moiseeva EV, Stewart RJE, Ziekman PGPM, Koten JW. Local therapy of cancer with free IL-2. Cancer Immunol Immunother 2008; 57: 931–50
   PubMed Web of Science ®Google Scholar
• Devrim B, Bozkır A, Canefe K, 2009. Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of recombinant human interleukin-2 microparticles, Proceedings of the 36th Annual & Exposition of the Controlled Release Society, Copenhagen-Denmark, July 18–22
   Google Scholar
• Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Controlled Release 2006; 112: 35–42
   PubMed Web of Science ®Google Scholar
• Fiedler W, Jasmin C, De Mulder PH, Pyrhonen S, Palmer PA, Franks CR, Oskam R, Hossfeld DK. A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma. Eur J Cancer 1992; 28(2–3)443–6
   PubMedGoogle Scholar
• Florindo HF, Pandit S, Lacerda L, Goncalves LMD, Alpar HO, Almeida AJ. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-3-caprolactone-based nanoparticles. Biomaterials 2009; 30: 879–91
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microspheres preparation process technology. J Controlled Release 2005; 102: 313–32
   PubMed Web of Science ®Google Scholar
• Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microsphers. J Controlled Release 2000; 69: 197–207
   PubMed Web of Science ®Google Scholar
• Giteau A, Venier-Julienne MC, Aubert-Pouessel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles?. Int J Pharm 2008; 350: 14–26
   PubMed Web of Science ®Google Scholar
• Holst-Hansen C, Brünner N. MTT-cell proliferation assay. Cell biology. A laboratory handbook, JE Celis. Academic Press, San Diego, CA 1998; 16–18
   Google Scholar
• Jeon H-J, Jeong Y-I, Jang M-K, Park Y-H, Nah J-W. Effect of solvent on the preparation of surfactant-free poly(lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm 2000; 207: 99–108
   PubMed Web of Science ®Google Scholar
• Khanna C, Anderson PM, Hasz DE, Katsanis E, Neville M, Klausner JS. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer, 1997;79(7):1409–21.
   Google Scholar
• Konrad MW, Hemstreet G, Hersh EM, Mansell PWA, Mertelsmann R, Kolitz JE. Bradley EC. Pharmacokinetics of recombinant interleukin-2 in humans. Cancer Res 1990; 50: 2009–17
   PubMed Web of Science ®Google Scholar
• Leonardi D, Salomón CJ, Lamas MC, Olivieri AC. Development of novel formulations for Chagas’ disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks. Int J Pharm 2009; 367: 140–7
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Yan R, Jia W, Yuan M, Deng X, Huang Z. Influence of process parameters on the protein stability encapsulated in poly-dl-lactide-poly(ethylene glycol) microspheres. J Controlled Release 2000; 68: 41–52
   PubMed Web of Science ®Google Scholar
• Maher SG, Condron CEM, Bouchier-Hayer DJ, Toomey DM. Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin Exp Immunol 2005; 139: 279–86
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of wow process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007; 334: 137–48
   PubMed Web of Science ®Google Scholar
• Matanić D, Beg-Zec Z, Stojanović D, Matakorić-Mileusnić N, Flego V, Milevoj-Ribić F. Cytokines in patients with lung cancer. Scand J Immunol 2003; 57: 173–8
   PubMedGoogle Scholar
• Meng FT, Ma GH, Qiu W, Su ZG. W/O/W double emulsion technique using ethyl acetate as organic solvent: Effects of its diffusion rate on the characteristics of microparticles. J Controlled Release 2003; 91: 407–16
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Controlled Release 2007; 119: 77–85
   PubMed Web of Science ®Google Scholar
• Nguyen T, Wang R, Russell JH. IL-12 enhances IL-2 function by inducing CD25 expression through a p38 mitogen-activated protein kinase pathway. Eur J Immunol 2000; 30: 1445–52
   PubMed Web of Science ®Google Scholar
• Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH. Interleukin-2 therapy in patients with metastatic malignant melanoma: A phase II study. J Clin Oncol 1990; 8(10)1650–6
   PubMed Web of Science ®Google Scholar
• Physician's Desk Reference (PDR), 61st ed. 2007. Montvale, NJ: Thomson PDR.
   Google Scholar
• Rawat A, Majumder QH, Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation. J Controlled Release 2008; 128: 224–32
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst 1994; 86(15)1159–66
   PubMed Web of Science ®Google Scholar
• Ruan G, Feng S-S, Li Q-T. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Controlled Release 2002; 84: 151–60
   PubMed Web of Science ®Google Scholar
• Sahana DK, Mittal G, Bhardwaj V, Ravi Kumar MNV. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2008; 97(4)1530–42
   PubMed Web of Science ®Google Scholar
• Spiers ID, Alpar HO, Eyles JE, Bozkir A, Miller J, Williamson ED. Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis. J Pharm Pharmacol 1999; 51: 991–7
   PubMed Web of Science ®Google Scholar
• Thomas TT, Kohane DS, Wang A, Langer R. Microparticulate formulations for the controlled release of interleukin-2. J Pharm Sci 2004; 93(5)1100–9
   PubMed Web of Science ®Google Scholar
• Vladisavljevi’c GT, Schubert H. Influence of process parameters on droplet size distribution in SPG membrane emulsification and stability of prepared emulsion droplets. J Membr Sci 2003; 225: 15–23
   Web of Science ®Google Scholar
• Wang R, Ciardelli TL, Russell JH. Partial signaling by cytokines: Cytokine regulation of cell cycle and fas-dependent, activation-induced death in CD4+ subsets. Cell Immunol 1997; 182: 152–60
   PubMedGoogle Scholar
• Yang Y-Y, Chung T-S, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231–41
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res 2004; 27(1)1–12
   PubMed Web of Science ®Google Scholar
• Yin J, Noda Y, Yotsuyanagi T. Properties of poly(lactic-co-glycolic acid) nanospeheres containing protease inhibitors: Camostat mesilate and nafamostat mesilate. Int J Pharm 2006; 314: 46–55
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu C-S, Yuan Y, Tao X-Y, Shan X-Q, Sheng Y, Wu F. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials 2007; 28: 1414–22
   PubMed Web of Science ®Google Scholar